NCT02471339View on ClinicalTrials.gov

Acceptance and Commitment Training for Adolescents and Young Adults With Neurofibromatosis Type 1, Plexiform Neurofibromas, and Chronic Pain

PHASE3CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

July 7, 2015

Primary Completion Date

December 23, 2020

Study Completion Date

December 23, 2020

Conditions
Neurofibromatosis Type 1Plexiform Neurofibromas
Interventions
BEHAVIORAL

Acceptance and Commitment Therapy (ACT)

Acceptance and Commitment Therapy (ACT), a newer generation of cognitive-behavioral therapy, focuses on encouraging individuals to engage in more adaptive ways of coping with pain.

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT02471339 - Acceptance and Commitment Training for Adolescents and Young Adults With Neurofibromatosis Type 1, Plexiform Neurofibromas, and Chronic Pain | Biotech Hunter | Biotech Hunter